Efficacy, safety and tolerability of imeglimin in patients with type 2 diabetes mellitus: A meta-analysis of randomized controlled trials.AIMS/INTRODUCTION
 This meta-analysis aimed to evaluate the efficacy and safety/tolerability of imeglimin, a novel oral antihyperglycemic agent, administered as monotherapy and adjunctive therapy in patients with type 2 diabetes mellitus.



Meta-analysis
Efficacy, safety and tolerability of imeglimin in patients with type 2 diabetes mellitus: A meta-analysis of randomized controlled trials.AIMS/INTRODUCTION
 Parallel-group randomized controlled trials comparing imeglimin with placebo in adults with type 2 diabetes mellitus were included.  Nine randomized controlled trials (n = 1,655) were included. 
Randomized controlled trials